Skip to main content
ModernaLaunch

What you need to know about updated COVID vaccines following FDA approval

What happened

Moderna received FDA approval for its updated mRNA COVID-19 vaccine targeting the XFG strain, which is now available for individuals from 6 months to 64 years with underlying conditions and all adults 65 and older.

Source

Article excerpt

Highlighted: the sentence this signal was extracted from

As summer winds down and children and teenagers across the U.S. head back to school, it also means updated COVID-19 vaccines are around the corner. This week, the Food and Drug Administration approved updated vaccines to protect against the predominant strain of the virus. Both Moderna and Pfizer received approval for their mRNA vaccines and Sanofi also received approval for a protein-based shot, similar to vaccines that have been around for decades. "Like the influenza virus, the COVID virus mutates; it changes notably over time, and so we have to update the vaccine in our best attempt to match the strain that we anticipate will be most active during the coming winter," Dr. William Schaffner, a professor of preventive medicine at Vanderbilt University Medical Center in Nashville, told ABC News. "The better the match we have with what's in the vaccine and the circulating strain, the more effective the vaccine will be." What strain does the updated vaccine target? The updated 2026-2027 COVID-19 vaccines target the XFG strain, a recombinant omicron variant, meaning it formed through the combination of two omicron subvariants. XFG currently accounts for about 40% of cases in the U.S., according to the latest data from the Centers for Disease Control and Prevention (CDC) in July. Who is eligible? Moderna's shot is approved for those 6 months through 64 years old with an...

Keep reading with a free account

The rest of this article, and every signal for Moderna, is in your free account.

Extracted by Autobound

From the Signal API record
Event
Launch

What this signalsA launch often needs new go-to-market and support spend.

Product
updated mRNA COVID-19 vaccine
Location
United States

Companies

  • Food and Drug AdministrationRelated companyfda.gov

The full record

From the Signal API record

Details

Release type
Update

Topics and mentions

Product tags

  • medical

Extraction

Confidence
90%
Detected
Aug 28, 2026
signal_type
news
signal_subtype
launches

Use this data

Get every launch signal for Moderna and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Moderna this week?”

  2. Send it to your own tools

    The Signal API returns launch signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full news record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/97a36f74-5892-898f-a02a-a6e2d51469e7 returns this record as JSON. POST /v1/companies/enrich returns every signal for modernatx.com.

{
  "signal_id": "97a36f74-5892-898f-a02a-a6e2d51469e7",
  "signal_type": "news",
  "signal_subtype": "launches",
  "detected_at": "2026-08-28T17:36:45+00:00",
  "company": {
    "name": "Moderna",
    "domain": "modernatx.com"
  },
  "data": {
    "url": "https://www.goodmorningamerica.com/amp/news/story/fda-approves-updated-covid-vaccines-136026783",
    "title": "What you need to know about updated COVID vaccines following FDA approval - Good Morning America",
    "excerpt": "As summer winds down and children and teenagers across the U.S. head back to school, it also means updated COVID-19 vaccines are around the corner. This week, the Food and Drug Administration approved updated vaccines to protect against the predominant strain of the virus. Both Moderna and Pfizer received approval for their mRNA vaccines and Sanofi also received approval for a protein-based shot, similar to vaccines that have been around for decades. \"Like the influenza virus, the COVID virus mutates; it changes notably over time, and so we have to update the vaccine in our best attempt to match the strain that we anticipate will be most active during the coming winter,\" Dr. William Schaffner, a professor of preventive medicine at Vanderbilt University Medical Center in Nashville, told ABC News. \"The better the match we have with what's in the vaccine and the circulating strain, the more effective the vaccine will be.\" What strain does the updated vaccine target? The updated 2026-2027 COVID-19 vaccines target the XFG strain, a recombinant omicron variant, meaning it formed through the combination of two omicron subvariants. XFG currently accounts for about 40% of cases in the U.S., according to the latest data from the Centers for Disease Control and Prevention (CDC) in July. Who is eligible? Moderna's shot is approved for those 6 months through 64 years old with an underlying...",
    "product": "updated mRNA COVID-19 vaccine",
    "summary": "Moderna received FDA approval for its updated mRNA COVID-19 vaccine targeting the XFG strain, which is now available for individuals from 6 months to 64 years with underlying conditions and all adults 65 and older.",
    "location": "United States",
    "planning": false,
    "image_url": "https://s.abcnews.com/images/Health/covid-ap-gmh-260828_1787927953295_hpMain_16x9_992.jpg",
    "confidence": 0.9,
    "product_data": {
      "name": "updated mRNA COVID-19 vaccine",
      "full_text": "updated mRNA vaccines",
      "fuzzy_match": false,
      "release_type": "update"
    },
    "product_tags": [
      "medical"
    ],
    "published_at": "2026-08-28T17:36:45Z",
    "location_data": [
      {
        "region": "Northern America",
        "country": "United States",
        "continent": "Americas",
        "fuzzy_match": false
      }
    ],
    "article_sentence": "Both Moderna and Pfizer received approval for their mRNA vaccines and Sanofi also received approval for a protein-based shot, similar to vaccines that have been around for decades.",
    "related_company_name": "Food and Drug Administration",
    "related_company_domain": "fda.gov"
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.